Viewing Study NCT00259103


Ignite Creation Date: 2025-12-24 @ 7:13 PM
Ignite Modification Date: 2025-12-25 @ 4:48 PM
Study NCT ID: NCT00259103
Status: COMPLETED
Last Update Posted: 2014-05-07
First Post: 2005-11-15
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Recombinant Human Relaxin (rhRlx) in Pregnant Women Scheduled for Induction of Labor
Sponsor: Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-11
Start Date Type: None
Primary Completion Date: 2006-10
Primary Completion Date Type: ACTUAL
Completion Date: 2006-10
Completion Date Type: ACTUAL
First Submit Date: 2005-11-15
First Submit QC Date: None
Study First Post Date: 2005-11-29
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-05-06
Last Update Post Date: 2014-05-07
Last Update Post Date Type: ESTIMATED